Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies-Reference-Cited by-同舟云学术

Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies

Published:2018-01-10 Issue:4 Volume:34 Page:725-733
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Cameron Chris¹,Zummo Jacqueline²,Desai Dharmik³,Drake Christine¹,Hutton Brian⁴,Kotb Ahmed⁵,Weiden Peter J.³

Affiliation:

1. Cornerstone Research Group Inc, Burlington, Canada;

2. Previously at Alkermes Inc, Waltham, MA, USA;

3. Alkermes Inc, Waltham, MA, USA;

4. Ottawa Hospital Research Institute, Ottawa, Canada;

5. Royal College of Surgeons of Ireland, Republic of Ireland

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1410471

Reference22 articles.

1. Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments

2. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

3. Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

4. Humanistic burden in schizophrenia: A literature review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of carbamazepine to expedite the metabolism of a long‐acting aripiprazole injection;Journal of Clinical Pharmacy and Therapeutics;2021-11-08

2. Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study;Clinical Psychopharmacology and Neuroscience;2021-05-31

3. From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs);Expert Review of Neurotherapeutics;2020-10-18

4. Antipsychotiques à Action Prolongée: Révision de l’algorithme QAAPAPLE;The Canadian Journal of Psychiatry;2019-05-14